文献速递创伤与烧伤消化、代谢与肾脏急症

创伤性颈段与胸段食管穿孔的当代管理:东部创伤外科协会多中心研究结果

Contemporary management of traumatic cervical and thoracic esophageal perforation: The results of an Eastern Association for the Surgery of Trauma multi-institutional study.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论创伤性食管损伤多数行手术直接修补;与食管支架相比,直接修补与较低的术后食管漏发生率相关(22.6% vs 80.0%,p=0.02),作者认为可能最好行直接修补而非食管支架,但仍需进一步研究。

本研究为东部创伤外科协会多中心回顾性研究,纳入2011至2016年11家参与创伤中心收治的创伤性颈段或胸段食管损伤患者51例。损伤位于颈段者69%、胸段者31%;初始管理以手术直接修补为主(61%),其次为无干预(19%)、食管支架(10%)和广泛局部引流(10%)。与手术直接修补相比,食管支架患者的食管漏发生率升高(22.6% vs 80.0%,p=0.02);钝性机制较穿透性机制并发症发生率更高(100% vs 31.8%,p=0.03),尽管损伤严重度评分与颈/胸/腹简明损伤定级相似。总死亡率9.8%,不因损伤部位、损伤机制或初始管理而异。作者认为创伤性食管损伤患者可能最好行直接修补而非食管支架,但仍需进一步研究。

要点

  • 创伤性食管损伤初始管理以手术直接修补为主(61%),其次为无干预(19%)、食管支架(10%)、广泛局部引流(10%)。
  • 与手术直接修补相比,食管支架患者食管漏发生率更高(22.6% vs 80.0%,p=0.02)。
  • 钝性机制较穿透性机制并发症发生率更高(100% vs 31.8%,p=0.03),尽管损伤严重度评分与颈/胸/腹简明损伤定级相似。
  • 总死亡率9.8%,不因损伤部位、损伤机制或初始管理而异。
  • 作者认为创伤性食管损伤患者可能最好行直接修补而非食管支架,但仍需进一步研究。

适用人群与场景

  • 2011至2016年收治于11家参与创伤中心的创伤性颈段或胸段食管损伤患者,共51例;颈段损伤69%,胸段损伤31%。

处置流程与药物剂量

  • 初始管理分布:手术直接修补61%、无干预19%、食管支架10%、广泛局部引流10%。

研究设计与关键结果

  • 多中心回顾性研究,纳入11家创伤中心2011至2016年创伤性颈段或胸段食管损伤患者51例。
  • 与手术直接修补相比,食管支架患者食管漏发生率更高(22.6% vs 80.0%,p=0.02)。
  • 钝性机制较穿透性机制并发症发生率更高(100% vs 31.8%,p=0.03),尽管损伤严重度评分与颈/胸/腹简明损伤定级相似。
  • 总死亡率9.8%,不因损伤部位、损伤机制或初始管理而异。

证据类型、等级与局限

  • 证据类型:东部创伤外科协会多中心回顾性研究;证据等级:治疗性,level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为创伤性食管损伤患者可能最好行直接修补而非食管支架,但仍需进一步研究。
  • 原文未据此给出其他推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic esophageal perforation is rare and associated with significant morbidity and mortality. There is substantial variability in diagnosis and treatment. Esophageal stents have been increasingly used for nontraumatic perforation; however, stenting for traumatic perforation is not yet standard of care. The purpose of this study was to evaluate current management of traumatic esophageal perforation to assess the frequency of and complications associated with esophageal stenting.

METHODS: This was an Eastern Association for the Surgery of Trauma multi-institutional retrospective study from 2011 to 2016 of patients with traumatic cervical or thoracic esophageal injury admitted to one of 11 participating trauma centers. Data were collected and sent to a single institution where it was analyzed. Patient demographics, injury characteristics, initial management, complications, and patient mortality were collected. Primary outcome was mortality; secondary outcomes were initial treatment, esophageal leak, and associated complications.

RESULTS: Fifty-one patients were analyzed. Esophageal injuries were cervical in 69% and thoracic in 31%. Most patients were initially managed with operative primary repair (61%), followed by no intervention (19%), esophageal stenting (10%), and wide local drainage (10%). Compared with patients who underwent operative primary repair, patients managed with esophageal stenting had an increased rate of esophageal leak (22.6% vs. 80.0%, p = 0.02). Complication rates were higher in blunt compared with penetrating mechanisms (100% vs. 31.8%, p = 0.03) despite similar Injury Severity Score and neck/chest/abdomen Abbreviated Injury Scale. Overall mortality was 9.8% and did not vary based on location of injury, mechanism of injury, or initial management.

CONCLUSION: Most patients with traumatic esophageal injuries still undergo operative primary repair; this is associated with lower rates of postoperative leaks as compared with esophageal stenting. Patients who have traumatic esophageal injury may be best managed by direct repair and not esophageal stenting, although further study is needed.

LEVEL OF EVIDENCE: Therapeutic, level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Raff LA, Schinnerer EA, Maine RG, et al. Contemporary management of traumatic cervical and thoracic esophageal perforation: The results of an Eastern Association for the Surgery of Trauma multi-institutional study. J Trauma Acute Care Surg. 2020. PMID: 32590561. doi:10.1097/TA.0000000000002841

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。